GENFIT (EPA:GNFT) | Finanzwire

PRESS RELEASE

published on 05/22/2025 at 22:10, 9 months 25 days ago

GENFIT Reports First Quarter 2025 Financial Information
GENFIT reports Q1 2025 financial information showing cash position growth and revenue increase. Details on Royalty Financing agreement, research efforts, and corporate governance update included

Financial Information Revenue Cash Position GENFIT Q1 2025
BRIEF

published on 05/20/2025 at 22:15, 9 months 27 days ago

GENFIT receives €26.5 million following a key milestone in Italy

Italy Primary Biliary Cholangitis GENFIT Milestone Payment Iqirvo®
PRESS RELEASE

published on 05/20/2025 at 22:10, 9 months 27 days ago

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GENFIT to receive a €26.5 million milestone payment for pricing approval of Ipsen's Iqirvo® in Italy. This unlocks a new phase for pipeline progress in liver diseases

Approval GENFIT Milestone Payment Ipsen Iqirvo®
BRIEF

published on 05/14/2025 at 22:15, 10 months 2 days ago

GENFIT Releases 2025 Extra-Financial Performance Report for 2024

Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
PRESS RELEASE

published on 05/14/2025 at 22:10, 10 months 2 days ago

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GENFIT publishes 2025 Extra-Financial Performance Report for fiscal year 2024. Focus on sustainability, ESG approach, social responsibility commitment, and liver disease research

Sustainability GENFIT ESG Approach 2025 Extra-Financial Performance Report Liver Disease Research
BRIEF

published on 05/07/2025 at 22:15, 10 months 9 days ago

GENFIT prepares its Combined General Meeting in June 2025

Biopharmaceuticals General Assembly Documentation GENFIT Online Voting
PRESS RELEASE

published on 05/07/2025 at 22:10, 10 months 9 days ago

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GENFIT announces Annual Combined General Meeting on June 17, 2025, providing shareholders with preparatory documents and online voting option. Company's focus on liver diseases and diverse R&D portfolio highlighted

Shareholders Annual Meeting Liver Diseases GENFIT R&D Portfolio
BRIEF

published on 05/05/2025 at 07:35, 10 months 12 days ago

GENFIT to Showcase ACLF Research at EASL Congress 2025

Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology
PRESS RELEASE

published on 05/05/2025 at 07:30, 10 months 12 days ago

GENFIT to Present Latest ACLF Research at EASL Congress 2025
GENFIT to Present Latest ACLF Research at EASL Congress 2025. Six posters on ACLF and diagnostic models. Events include EASL Studio and ACLF Patient Advocacy Council session

Research GENFIT ACLF EASL Congress Posters
BRIEF

published on 04/29/2025 at 21:15, 10 months 17 days ago

GENFIT Publishes its 2024 Annual Reports

Annual Report Biopharmaceuticals Registration Document Liver Diseases GENFIT

Published on 03/17/2026 at 12:30, 37 minutes ago

Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho
Published on 03/17/2026 at 12:30, 37 minutes ago

Gold Basin Resources Announces Results of Annual General Meeting
Published on 03/17/2026 at 12:30, 37 minutes ago

Canex Announces Results of Gold Basin Resources Corporation Annual General Meeting
Published on 03/17/2026 at 12:25, 42 minutes ago

Reeflex Solutions Inc. Announces Filing of Financial Statements
Published on 03/17/2026 at 12:00, 1 hour 7 minutes ago

Eagle Plains Partner Refined Energy Completes First Drill Hole at Dufferin West; Second Hole Underway to Test High-Priority EM Conductor

View all ACCESSWIRE

Published on 03/17/2026 at 12:08, 59 minutes ago

Notice of the 2026 annual general meeting of Ørsted A/S
Published on 03/17/2026 at 12:02, 1 hour 4 minutes ago

Enapter AG expands global Core Partner network with U.S.-based Total Hydrogen Solutions
Published on 03/17/2026 at 12:00, 1 hour 7 minutes ago

Nebius Group announces proposed private offering of $3.75 billion of convertible senior notes
Published on 03/17/2026 at 11:48, 1 hour 19 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/17/2026 at 11:42, 1 hour 24 minutes ago

Amundi Physical Metals plc: Final Terms

View all EQS

Published on 03/17/2026 at 07:00, 6 hours 7 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 19 hours 7 minutes ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 19 hours 9 minutes ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 19 hours 10 minutes ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 19 hours 22 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News